ARCHIVES

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 18 No. 46 | November 27, 1992

Download PDF Visit The Full Archive

Related Articles

Senate Committee Passes Bill To Speed FDA Approval Of Follow-On Biologics.

June 29, 2007

National Cancer Policy Board calls for public-private partnership for R&D in pediatric cancer drugs.

April 22, 2005

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

Epstein Petition Seeks Broder’s Removal As NCI Director

February 5, 1993

Michael Friedman To Head PhRMA’s Office Of Biomedical Preparedness.

November 2, 2001

Abrams, Tomaszewski To Co-Direct DCTD

June 10, 2011